In September, we invested nearly $2 billion to increase our manufacturing footprint in Ireland. The Irish investment which includes GLP-1s but will also support other products in Lillys portfolio, including the recently approved Alzheimer's disease treatment Kisunla (donanemab) followed investments of $5.3 billion at a site in Indiana, $2 billion in North Carolina, and $2.5 billion in Germany
Virtus Peptides' own role begins after sourcing: every batch passes independent release testing, with the final Certificate of Analysis issued by ILS Laboratories
For supplement brands, taurine is attractive because it is generally neutral in taste compared with many bitter amino acids, dissolves well in water-based systems, and can be positioned for hydration, endurance, active lifestyle, and energy-support formulas
daily use over time typically yields the best outcomes
LC3 expression depends, among others, on the activity of SIRT1, transcription factor EB (TFEB), histone acetyltransferase (HAT) and p300 HAT (EP300)